| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |